Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms in North America.
Happy #NationalFreelancersDay to the fantastic independent specialists on our roster! You bring valued expertise, a fresh perspective and true dedication to our mission: to help our clients bring evidence-based treatments to patients in areas of unmet medical need. Thank you! https://t.co/71ZsLqPC5w
Every Friday between 1 June and 31 August 2021, our office hours will end at the earlier time of 16:00. These 'summer hours' will help our colleagues worldwide to make the most of weekends, and return even more energized to keep delivering life-changing projects for our clients! https://t.co/9lDnVkhRUI
Monday 10 May to Wednesday 12 May
2021 Clinical Data Disclosure, Transparency and Plain Language Summaries
Oxford PharmaGenesis is helping to raise public awareness of the importance of patient diversity in clinical trials through a campaign partnership with the non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP).
Oxford PharmaGenesis continues to boost colleagues’ skills and expertise through a wide range of professional and personal development sessions offered to celebrate Learning at Work Week 2021 (17–23 May).
Monday 10 May to Wednesday 12 May A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS). However, the important role of different forms of plain language […]
Kidney disease consensus manuscript published: highlights the need to improve awareness of racial health disparities
Oxford PharmaGenesis is proud to announce the publication of a Delphi consensus manuscript in the Journal of the American Society of Nephrology. The publication highlights the need to increase awareness among key stakeholders of racial health disparities in kidney disease and of APOL1-associated nephropathy.
Oxford PharmaGenesis has made its first appointments to the new role of Director of Innovation, created specifically to support teams across the global organization in utilizing new and emerging technology to support their clients’ unmet needs.